Cargando…
Intelligent discussion on HIV vaccine serves as a small consolation for slow progress: Bicentennial Symposium
Despite great public interest and desperate need, progress toward a viable human immunodeficiency virus (HIV) vaccine remains incredibly slow. Since Merck began its HIV vaccine research in 1985, the pharmaceutical company has yet to produce a vaccine capable of passing Phase II testing. Merck Labora...
Autor principal: | Reed, Harrison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117411/ https://www.ncbi.nlm.nih.gov/pubmed/21698049 |
Ejemplares similares
-
Reflections of a Member of the Bicentennial Class on the Bicentennial Symposium
por: Gold, Jessica
Publicado: (2011) -
Creating the Unforgettable: The Short Story of Mapping Long-Term Memory: Bicentennial Symposium
por: Wang, Samantha X.Y.
Publicado: (2011) -
The Birth of Chemotherapy at Yale: Bicentennial Lecture Series: Surgery Grand Round
por: Christakis, Panos
Publicado: (2011) -
Close to Home: A History of Yale and Lyme Disease
por: Elbaum-Garfinkle, Shana
Publicado: (2011) -
Pioneering Studies of the “Morning-After” Pill
por: Kunjappu, Mary J.
Publicado: (2011)